title: Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab.
authors.forename: D
authors.initials: D
authors.lastname: McGonagle
authors.forename: A L
authors.initials: AL
authors.lastname: Tan
authors.forename: J
authors.initials: J
authors.lastname: Madden
authors.forename: A C
authors.initials: AC
authors.lastname: Rawstron
authors.forename: A
authors.initials: A
authors.lastname: Rehman
authors.forename: P
authors.initials: P
authors.lastname: Emery
authors.forename: S
authors.initials: S
authors.lastname: Thomas
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000188:drug therapy*; D000069283:Rituximab; D012595:Scleroderma, Systemic / Q000150:complications*; D014057:Tomography, X-Ray Computed
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab